Back
Compare AU
Compare CURE vs. FOOD
Compare shares and ETFs on the ASX that you can trade on Pearler.
Overview
When it comes to investing in the Australian stock market, Exchange-Traded Funds (ETFs) are a popular choice. Two well-known options in the Australian Securities Exchange (ASX) are the Global X S&P Biotech ETF (CURE) and the Betashares Glb Agriculture Comp Currency Hdgd ETF (FOOD). In this comparison, we'll delve into these ETFs across various dimensions to help you make an informed investment decision.
Community Stats
CURE | FOOD | |
|---|---|---|
Popularity | Low | Low |
Pearlers invested | 82 | 63 |
Median incremental investment | $678.72 | $1,010.80 |
Median investment frequency | Monthly | Monthly |
Median total investment | $2,196.90 | $1,669.92 |
Average age group | > 35 | > 35 |
Key Summary
CURE | FOOD | |
|---|---|---|
Strategy | CURE.AX was created on 2018-11-08 by Global X. The fund's investment portfolio concentrates primarily on health care equity. The ETF currently has 46.59m in AUM and 158 holdings. The Fund aims to provide investors with a return that (before fees and expenses) tracks the performance of the S&P Biotechnology Select Industry Index. | FOOD.AX was created on 2016-08-02 by BetaShares. The fund's investment portfolio concentrates primarily on theme equity. The ETF currently has 82.9m in AUM and 60 holdings. The Investment objective of the Betashares Global Agriculture Companies ETF - Currency Hedged is to provide an investment returns that aims to track the performance of the Nasdaq Global ex - Australia company hedged AUD Index. |
Top 3 holdings | Moderna Inc (2.36 %) Twist Bioscience Corp (1.98 %) Natera Inc (1.90 %) | CAD - CANADA DOLLAR (0 %) CHF - SWISS FRANC (0 %) AUD - AUSTRALIA DOLLAR (0 %) |
Top 3 industries | Health Care (100.00 %) Other (10.24 %) | Other (83.95 %) Communication Services (33.94 %) Consumer Staples (6.64 %) |
Top 3 countries | United States (96.74 %) Switzerland (1.43 %) United Kingdom of Great Britain and Northern Ireland (1.23 %) | United States (48.33 %) Japan (16.84 %) Canada (8.85 %) |
Management fee | 0.45 % | 0.47 % |
Key Summary
CURE | FOOD | |
|---|---|---|
Issuer | Global X | BetaShares |
Tracking index | S&P Biotechnology Select Industry | Nasdaq Global ex-Australia Agriculture Companies Hedged AUD Index - AUD |
Asset class | ETF | ETF |
Management fee | 0.45 % | 0.47 % |
Price | $73.23 | $7.84 |
Size | $48.959 million | $82.732 million |
10Y return | N/A | 54.64 % |
Annual distribution yield (5Y) | 0.03 % | 2.32 % |
Market | ASX | ASX |
First listed date | 12/11/2018 | 04/08/2016 |
Purchase fee | $6.50 | $6.50 |
Community Stats
CURE | FOOD | |
|---|---|---|
Popularity | Low | Low |
Pearlers invested | 82 | 63 |
Median incremental investment | $678.72 | $1,010.80 |
Median investment frequency | Monthly | Monthly |
Median total investment | $2,196.90 | $1,669.92 |
Average age group | > 35 | > 35 |
Pros and Cons
CURE | FOOD | |
|---|---|---|
Pros |
|
|
Cons |
|
|
CURE | FOOD |
|---|---|
Higher exposure to US market | Lower exposure to US market |
Lower management fee | Higher management fee |
Higher price growth | Lower price growth |
Lower distribution yield | Higher distribution yield |